Last reviewed · How we verify
AGSPT201 Tab contains S-pantoprazole
AGSPT201 Tab contains S-pantoprazole is a Proton pump inhibitor (PPI) Small molecule drug developed by Ahn-Gook Pharmaceuticals Co.,Ltd. It is currently in Phase 3 development for Gastroesophageal reflux disease (GERD), Peptic ulcer disease, Acid-related gastrointestinal disorders. Also known as: AGSPT201 Tab. (Brand name Deflux tab).
S-pantoprazole inhibits the proton pump in gastric parietal cells, reducing gastric acid secretion.
S-pantoprazole inhibits the proton pump in gastric parietal cells, reducing gastric acid secretion. Used for Gastroesophageal reflux disease (GERD), Peptic ulcer disease, Acid-related gastrointestinal disorders.
At a glance
| Generic name | AGSPT201 Tab contains S-pantoprazole |
|---|---|
| Also known as | AGSPT201 Tab. (Brand name Deflux tab) |
| Sponsor | Ahn-Gook Pharmaceuticals Co.,Ltd |
| Drug class | Proton pump inhibitor (PPI) |
| Target | H+/K+-ATPase (proton pump) |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | Phase 3 |
Mechanism of action
S-pantoprazole is the active S-enantiomer of pantoprazole, a proton pump inhibitor (PPI) that irreversibly binds to and blocks the H+/K+-ATPase enzyme in the gastric mucosa. This reduces intragastric acid production, providing relief from acid-related gastrointestinal conditions. The S-enantiomer is the pharmacologically active form responsible for acid suppression.
Approved indications
- Gastroesophageal reflux disease (GERD)
- Peptic ulcer disease
- Acid-related gastrointestinal disorders
Common side effects
- Headache
- Diarrhea
- Nausea
- Abdominal pain
- Constipation
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AGSPT201 Tab contains S-pantoprazole CI brief — competitive landscape report
- AGSPT201 Tab contains S-pantoprazole updates RSS · CI watch RSS
- Ahn-Gook Pharmaceuticals Co.,Ltd portfolio CI
Frequently asked questions about AGSPT201 Tab contains S-pantoprazole
What is AGSPT201 Tab contains S-pantoprazole?
How does AGSPT201 Tab contains S-pantoprazole work?
What is AGSPT201 Tab contains S-pantoprazole used for?
Who makes AGSPT201 Tab contains S-pantoprazole?
Is AGSPT201 Tab contains S-pantoprazole also known as anything else?
What drug class is AGSPT201 Tab contains S-pantoprazole in?
What development phase is AGSPT201 Tab contains S-pantoprazole in?
What are the side effects of AGSPT201 Tab contains S-pantoprazole?
What does AGSPT201 Tab contains S-pantoprazole target?
Related
- Drug class: All Proton pump inhibitor (PPI) drugs
- Target: All drugs targeting H+/K+-ATPase (proton pump)
- Manufacturer: Ahn-Gook Pharmaceuticals Co.,Ltd — full pipeline
- Therapeutic area: All drugs in Gastroenterology
- Indication: Drugs for Gastroesophageal reflux disease (GERD)
- Indication: Drugs for Peptic ulcer disease
- Indication: Drugs for Acid-related gastrointestinal disorders
- Also known as: AGSPT201 Tab. (Brand name Deflux tab)
- Compare: AGSPT201 Tab contains S-pantoprazole vs similar drugs
- Pricing: AGSPT201 Tab contains S-pantoprazole cost, discount & access